USPTO serial 78104612
DNAFORM
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 2, 2005
- Examiner
- NADELMAN, ANDREA KOYNER
- Law office
- TMO LAW OFFICE 110
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with DNAFORM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Minata-ku, Tokyo, 108-0073, JP
Minata-ku, Tokyo, 108-0073, JP
Yokohama-shi, Kanagawa, JP
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Charles E. Bruzga
Charles E. Bruzga Bruzga & Associates11 Broadway, Suite 715New York, NY 10004UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in scientific and medical research preparations, namely DNA, cDNA, cDNA clones, cDNA library, RNA, plasmid, peptide, cDNA fragment, antibody and antisense, chromatography chemicals; chemical additives for use in the manufacture of cosmetics, chemical additives for use in the manufacture of pharmaceuticals; diagnostic preparations for scientific and research use, diagnostic reagents for scientific and research use, diagnostic reagents containing DNA, diagnostic reagents containing RNA, diagnostic reagents containing vectors, diagnostics reagents for protein expression, protein-protein interaction reagents for use in scientific and medical research, PCR preparation kits comprised of diagnostic reagents for scientific and medical research | SECTION 8 - CANCELLED | May 24, 2004 |
| 042 | Testing, inspection or research of pharmaceuticals, cosmetics or foodstuff, namely research of cosmetics, research of pharmaceuticals, research on pharmaceutical drug development, medical testing, scientific research, diagnostics research; Scientific and medical research relating to genes or proteins, namely research of genome, research of DNA, research of protein, research of proteomics; Scientific and medical research relating to genes and proteins namely DNA sequence, amino-acid sequence, protein sequence, DNA, protein expression analysis, providing information in the field of genomics and proteomes; providing bioinformatics research analysis | SECTION 8 - CANCELLED | Mar 20, 2003 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Kabushiki Kaisha Dnaform
- Other trademarks owned by Kabushiki Kaisha Dnaform
- Other trademarks owned by Kabushiki Kaisha Dnaform
- Other trademarks in Class 001
- Other trademarks in Class 042
- Similar marks named DNAFORM
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 4, 2016 | CAEX | CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9 | — |
| Mar 26, 2011 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Mar 26, 2011 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Mar 25, 2011 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Nov 18, 2009 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 18, 2009 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 17, 2009 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Nov 17, 2009 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 2, 2005 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 18, 2005 | REGV | LAW OFFICE REGISTRATION REVIEW COMPLETED | — |
| Jun 17, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jun 14, 2005 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jun 9, 2005 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 7, 2005 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jun 7, 2005 | IUAF | USE AMENDMENT FILED | — |
| Jun 7, 2005 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Apr 26, 2005 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jan 5, 2005 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 21, 2004 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 21, 2004 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jun 22, 2004 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Mar 30, 2004 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 12, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 10, 2004 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 31, 2004 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 12, 2004 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 12, 2004 | PAPER RECEIVED | — | |
| Jan 5, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 4, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 4, 2003 | PAPER RECEIVED | — | |
| Nov 17, 2003 | CNSL | LETTER OF SUSPENSION MAILED | — |
| Nov 13, 2003 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Oct 29, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 3, 2003 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 3, 2003 | PAPER RECEIVED | — | |
| Aug 29, 2003 | CFIT | CASE FILE IN TICRS | — |
| Jul 28, 2003 | UNPR | UNRESPONSIVE/DUPLICATE PAPER RECEIVED | — |
| Jul 28, 2003 | PAPER RECEIVED | — | |
| Apr 28, 2003 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 12, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 12, 2002 | PAPER RECEIVED | — | |
| Oct 9, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2002 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 29, 2002 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 1, 2002 | AMPX | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | — |
| Apr 1, 2002 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 1, 2002 | PAPER RECEIVED | — |